fda covid shots - Search News

Order byBest matchMost fresh

FDA plans to limit COVID vaccine to only high-risk people

FDA plans to limit COVID shots to those over 65 or with high-risk conditions

the Food and Drug Administration has announced a plan to limit access to future COVID-19 shots only to people over 65 years old or those with an underlying health condition.

· 1d · on MSN

Scientific American · 1h

What FDA’s Planned Limits on COVID Vaccinations Mean for Health

· 1d

FDA won’t approve COVID shot for healthy, non-elderly population

InnovationRx: FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

Under this guidance, published in the New England Journal of Medicine, recommendations for booster shots will be limited to those 65 and older and people with high risk for severe outcomes.

· 1d

· 2d

New FDA policy may make COVID-19 boosters harder to get

wtvr · 18h

FDA advisory committee meets on COVID-19 vaccine after putting new restrictions on approvals

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 1d

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

· 1d

Why the FDA is limiting access to COVID-19 vaccines

28mon MSN

COVID shots should target newer strains of JN.1 variant, US FDA advisers say

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are seeing increased regulatory scrutiny under the new FDA leadership,

The F.D.A. May Restrict Covid Shots. Who Will Be Able to Get Them?

Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all Americans over 6 months of age.

18hon MSN

FDA panel is split on updates to COVID shots as questions loom for fall vaccinations

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter.

20h

FDA panel recommends keeping COVID shots targeted to same strain as last year

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their booster doses to the “JN.1” coronavirus lineage.

17hon MSN

How the FDA Might Make It Harder to Get COVID Shots This Year

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall, but FDA officials published a policy position in the New England Journal of Medicine announcing that it intends to make some drastic policy changes.

16hon MSN

With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,

20hon MSN

COVID shots should target newer strains of JN.1 variant in 2025-26 campaign, US FDA advisers say

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. According to the Centers for Disease Control and Prevention,